B. Riley Securities Maintains Buy on Enovix, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 74.5%

Neg 74.5% Neu 0% Pos 0%

B. Riley Securities analyst Ryan Pfingst maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $10 to $9.